Catalogue


A comprehensive guide to toxicology in preclinical drug development [electronic resource] /
edited by Ali S. Faqi.
edition
1st ed.
imprint
London ; Waltham, MA : Academic Press, 2013.
description
xvi, 885 p. : ill. ; 28 cm.
ISBN
0123878152, 9780123878151
format(s)
Book
More Details
added author
imprint
London ; Waltham, MA : Academic Press, 2013.
isbn
0123878152
9780123878151
restrictions
Licensed for access by U. of T. users.
abstract
A Comprehensive Guide to Toxicology in Preclinical Drug Development is designed for toxicologists who need a thorough understanding of the drug development process. This multi-contributed reference will provide a detailed picture of the complex and highly interrelated activities of preclinical toxicology in both small molecules and biologics --
catalogue key
8704899
 
Includes bibliographical references and index.
A Look Inside
Reviews
Review Quotes
"Incorporating real-life case studies and examples, the book is a practical guide that outlines day-to-day activities and experiences in preclinical toxicology.By incorporating the latest research in this area and featuring practical scenarios, this reference is a complete and actionable guide to all aspects of preclinical drug testing."-- VeterinaryWorld.org, April 17, 2013
To find out how to look for other reviews, please see our guides to finding book reviews in the Sciences or Social Sciences and Humanities.
Summaries
Bowker Data Service Summary
This guide is designed for toxicologists who need a thorough understanding of the drug development process. It will provide a detailed picture of the complex and highly interrelated activities of preclinical toxicology in both small molecules and biologics. Intended as a comprehensive resource for toxicologists in industry and regulatory settings, as well as directors working in contract resource organizations (CRO), this book will discuss discovery toxicology and the international guidelines for safety evaluation and present both traditional and nontraditional toxicology models.
Main Description
"A Comprehensive Guide to Toxicology in Preclinical Drug Development "is a resource for toxicologists in industry and regulatory settings, as well as directors working in contract resource organizations, who need a thorough understanding of the drug development process. Incorporating real-life case studies and examples, the book is a practical guide that outlines day-to-day activities and experiences in preclinical toxicology. This multi-contributed reference provides a detailed picture of the complex and highly interrelated activities of preclinical toxicology in both small molecules and biologics. The book discusses discovery toxicology and the international guidelines for safety evaluation, and presents traditional and nontraditional toxicology models. Chapters cover development of vaccines, oncology drugs, botanic drugs, monoclonal antibodies, and more, as well as study development and personnel, the role of imaging in preclinical evaluation, and supporting materials for IND applications. By incorporating the latest research in this area and featuring practical scenarios, this reference is a complete and actionable guide to all aspects of preclinical drug testing. Chapters written by world-renowned contributors who are experts in their fieldsIncludes the latest research in preclinical drug testing and international guidelinesCovers preclinical toxicology in small molecules and biologics in one single source
Main Description
A Comprehensive Guide to Toxicology in Preclinical Drug Development is a resource for toxicologists in industry and regulatory settings, as well as directors working in contract resource organizations, who need a thorough understanding of the drug development process. Incorporating real-life case studies and examples, the book is a practical guide that outlines day-to-day activities and experiences in preclinical toxicology. This multi-contributed reference provides a detailed picture of the complex and highly interrelated activities of preclinical toxicology in both small molecules and biologics. The book discusses discovery toxicology and the international guidelines for safety evaluation, and presents traditional and nontraditional toxicology models. Chapters cover development of vaccines, oncology drugs, botanic drugs, monoclonal antibodies, and more, as well as study development and personnel, the role of imaging in preclinical evaluation, and supporting materials for IND applications. By incorporating the latest research in this area and featuring practical scenarios, this reference is a complete and actionable guide to all aspects of preclinical drug testing. Chapters written by world-renowned contributors who are experts in their fields Includes the latest research in preclinical drug testing and international guidelines Covers preclinical toxicology in small molecules and biologics in one single source
Main Description
A Comprehensive Guide to Toxicology in Preclinical Drug Development is designed for toxicologists who need a thorough understanding of the drug development process. This multi-contributed reference will provide a detailed picture of the complex and highly interrelated activities of preclinical toxicology in both small molecules and biologics. Intended as a comprehensive resource for toxicologists in industry and regulatory settings, as well as directors working in contract resource organizations (CRO), this book will discuss discovery toxicology and the international guidelines for safety evaluation and present both traditional and nontraditional toxicology models. By incorporating the latest research in this area and featuring real-life examples and scenarios, this reference is a complete and practical guide to all aspects of preclinical drug testing. Chapters written by world-renowned contributors who are experts in their fields. Includes the latest research in preclinical drug testing and international guidelines. Covers preclinical toxicology in small molecules and biologics in one single source. Incorporates real-life case studies and examples and offers readers a practical resource that outlines day-to-day activities and experiences in preclinical toxicology.
Table of Contents
Introduction
Discovery ADME
Pharmacokinetics/Toxicokinetics
Development of Preclinical Formulations for Toxicology Studies
Acute, sub-acute and chronic toxicity testing
Safety Pharmacology
Genetic Toxicology
Clinical Pathology
Best Practice in Toxicologic Pathology
Molecular pathology in preclinical Toxicology
Infusion Toxicology
The Preparation of a Preclinical Dossier to Support an Investigational New Drug (IND) Application and First-in-Human Clinical Trials
Developmental & Reproductive Toxicology
Immunotoxicology
Toxicity Studies to Support Clinical Trials in Pediatric Population
Photoxicity
Preclinical Evaluation of Carcinogenicity using the Rodent Two-Year Bioassay
Carcinogenicity Evaluations using Genetically Engineered Animals
Current Strategies for Abuse Liability Assessment of New Chemical Entities
Impact of product attributes on preclinical safety evaluation
Preclinical Development of Monoclonal Antibodies
Preclinical Development of Non-Oncogenic Drugs (Small and Large Molecules)
Preclinical Development of Oncology Drugs
Safety Evaluation of Ocular Drugs
Preclinical toxicology of vaccines
Overview of the Nonclinical Development Strategies and Class-Effects of Oligonucleotide-Based Therapeutics
Preclinical Development of Botanical Drugs
Regulatory Toxicology
Chinese Drug Regulations
Biostatistics for Toxicologists
Study Director and Preclinical Study Monitoring Role
Use of Imaging for Preclinical Evaluation
Predictive Toxicology
Metabolics in Toxicology
Toxicogenomics in Drug Development
Practical Aspects of Developing In-Licensed Pharmaceutical Products: The Virtual Development Paradigm to Toxicology in Preclinical Drug Development
Table of Contents provided by Publisher. All Rights Reserved.

This information is provided by a service that aggregates data from review sources and other sources that are often consulted by libraries, and readers. The University does not edit this information and merely includes it as a convenience for users. It does not warrant that reviews are accurate. As with any review users should approach reviews critically and where deemed necessary should consult multiple review sources. Any concerns or questions about particular reviews should be directed to the reviewer and/or publisher.

  link to old catalogue

Report a problem